学术简历
医学博士(中国医科大学)
法医学学士(中国医科大学)
中国医科大学博士,主持省部级项目1项。在JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, Journal of Cancer,J Cell Mol Med.等国际期刊发表SCI论文共11篇,其中第一或通信作者论文1篇;主要研究方向为呼吸系统与女性生殖系统的肿瘤的发生发展的分子机制研究。
社会兼职
新疆医学会第一届病理学专业青年委员会委员
主要承担或参与的课题(5-6项代表性课题)
1. 1.新疆维吾尔自治区科学技术厅, 自然科学基金青年项目, 2020D01C175, DRAM2通过p53信号通路调控非 小细胞肺癌自噬的研究, 2020-06 至 2023-05, 7万元, 在研, 主持
2.新疆维吾尔自治区科学技术厅, 省部级, 2022B03019-1, 新疆女性乳腺癌、宫颈癌早筛预警指标及关键技术研究和一体化精准诊疗体系的构建-遗传变异介导的免疫失衡在宫颈癌发生及免疫逃逸中的作用及机制研究, 2023-01 至 2026-12, 130万元, 在研, 参与
3.国家自然科学基金委员会, 地区科学基金项目, 82260516, E6介导AIM2炎症小体调控脂肪酸合成促进 宫颈癌侵袭和淋巴转移的作用及机制研究, 2023-01-01 至 2026-12-31, 33万元, 在研, 参与
4.国家自然科学基金委员会, 地区科学基金项目, 82060473, NEAT1/miR-101/RAC1在宫颈癌细胞侵袭性 伪足形成中的作用和机制, 2021-01-01 至 2024-12-31, 34万元, 在研, 参与
5.新疆维吾尔自治区科学技术厅, 天山创新团队计划项目, 2021D14002, 新疆高发肿瘤宫颈癌基础研究 创新团队, 2021-08 至 2023-08, 50万元,结题, 参与
近期发表的主要文章, * 通信作者'
1. Wudu muli; Hongjiu Ren; Linping Hui; Jun Jiang; Siyang Zhang; Yitong Xu; Qiongzi Wang; Hongbo Su; Xizi Jiang; Runa Dao; Xueshan Qiu ; DRAM2 Acts as an Oncogene in Non-Small Cell Lung Cancer and Suppresses the Expression of p53,JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38(1): 72 (期刊论文)
2. Runa Dao;Muli Wudu; Linping Hui; Jun Jiang; Yitong Xu; Hongjiu Ren; Xueshan Qiu ; Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p,Pathology - Research and Practice, 2020, 216(3).
3. Jun Jiang; Yitong Xu; Hongjiu Ren;Muli Wudu; Qiongzi Wang; Xin Song; Hongbo Su; Xizi Jiang; Lihong Jiang; Xueshan Qiu ; MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway,Journal of Experimental & Clinical Cancer Research,2018, 37 (1): 189.
4. Xizi Jiang; Jingqian Guan; Yitong XU; Hongjiu Ren; Jun Jiang; Muli Wudu; Qiongzi Wang; Hongbo SU; Yao Zhang; Bo Zhang; Zifang Zou; Yujiao Hu; Xiaodan SUN; Xueshan Qiu ; Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1,Journal of Cancer , 2021, 12(2): 387-396.
5. Yao Zhang; Hongbo Su;Muli Wudu; Hongjiu Ren; Yitong Xu; Qingfu Zhang; Jun Jiang; Qiongzi Wang; Xizi Jiang; Bo Zhang; Zongang Liu; Zifang Zou; Xueshan Qiu ; TBC1 domain family member 23 interacts with Ras-related protein Rab-11A to promote poor prognosis of non-small-cell lung cancer via β1-integrin,J Cell Mol Med., 2021, 25(18): 8821-8835.
6. Wang Q, Ren H, Xu Y, Jiang J,Wudu M, Liu Z, Su H, Jiang X, Zhang Y, Zhang B, Qiu X. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.Exp Cell Res. 2020 Feb 15;387(2):111806.
7. Zhang B, Zhang Y, Jiang X, Su H, Wang Q, Wudu M, Jiang J, Ren H, Xu Y, Liu Z, Qiu X. JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation.J Cancer. 2021 Jan 1;12(4):976-987.
8. Hui L, Zhang S,Wudu M, Ren H, Xu Y, Zhang Q, Qiu X. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.Thorac Cancer. 2019 Jun;10(6):1479-1488.
9. Jiang X, Xu Y, Ren H, Jiang J,Wudu M, Wang Q, Guan J, Su H, Zhang Y, Zhang B, Guo Y, Hu Y, Jiang L, Liu Z, Wang H, Cheng Y, Sun L, Qiu X. KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity.Cell Biosci. 2020 Nov 27;10(1):139.
10. Xu Y, Ren H, Jiang J, Wang Q, Wudu M, Zhang Q, Su H, Wang C, Jiang L, Qiu X. KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.Cancer Sci. 2018 Apr;109(4):1055-1065.
11. Jiang J, Ren H, Xu Y, Wudu M,Wang Q, Liu Z, Su H, Jiang X, Zhang Y, Zhang B, Qiu X. TRIM67 Promotes the Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Positively Regulating the Notch Pathway. J Cancer. 2020 Jan 1;11(5):1240-1249.
研究生与博士后培养、专职科研人员招聘
1. 硕士研究生(方向:病理学与病理生理学)